Page last updated: 2024-08-24

gemcitabine and Bilirubinemia

gemcitabine has been researched along with Bilirubinemia in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's3 (60.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Arima, F1
Bahra, M; Denecke, T; Jühling, A; Klein, F; Pelzer, U; Riess, H; Roemmler-Zehrer, J; Sinn, M; Striefler, J; Wislocka, L1
Beijnen, JH; Cerny, T; Gillessen, S; Hitz, F; Huitema, AD; Joerger, M; Koeberle, D; Rosing, H; Schellens, JH1
Al-Batran, SE; Kullmann, F; Kunzmann, V; Oettle, H; Plentz, R; Riess, H; Siveke, J; Springfeld, C; Vogel, A1
Aguilar, EA; Carbonero, AI; Delgado, FJ; Espinosa, JC; García López, JL; García Ribas, I; García, JJ; Guzmán, MC; Jericó, JF; Martos, CF; Mena, AC; Muñoz, ML; Plazas, JG; Rovira, PS; Santasusana, JM; Valera, JS1

Reviews

1 review(s) available for gemcitabine and Bilirubinemia

ArticleYear
Patients with Advanced Pancreatic Cancer and Hyperbilirubinaemia: Review and German Expert Opinion on Treatment with nab-Paclitaxel plus Gemcitabine.
    Oncology research and treatment, 2015, Volume: 38, Issue:11

    Topics: Albumins; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Evidence-Based Medicine; Expert Testimony; Gemcitabine; Germany; Humans; Hyperbilirubinemia; Paclitaxel; Pancreatic Neoplasms; Treatment Outcome

2015

Trials

1 trial(s) available for gemcitabine and Bilirubinemia

ArticleYear
A phase II trial of gemcitabine and weekly high-dose 5-fluorouracil in a 48-hour continuous-infusion schedule in patients with advanced pancreatic carcinoma. A study of the Spanish Cooperative Group for Gastrointestinal Tumour Therapy (TTD).
    Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2005, Volume: 7, Issue:11

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Disease-Free Survival; Drug Administration Schedule; Female; Fluorouracil; Follow-Up Studies; Gemcitabine; Humans; Hyperbilirubinemia; Infusions, Intravenous; Male; Middle Aged; Mucositis; Neutropenia; Pancreatic Neoplasms; Patient Compliance; Quality of Life; Spain; Survival Analysis; Treatment Outcome

2005

Other Studies

3 other study(ies) available for gemcitabine and Bilirubinemia

ArticleYear
[A Case of Non-Hodgkin Lymphoma with Liver Involvement and Severe Jaundice That Benefited from Therapy with Gemcitabine, Carboplatin, Dexamethasone(GCD)Therapy with Rituximab].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2023, Volume: 50, Issue:11

    Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cyclophosphamide; Dexamethasone; Doxorubicin; Gemcitabine; Humans; Hyperbilirubinemia; Jaundice; Liver Diseases; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Rituximab; Treatment Outcome; Vincristine

2023
Safety and efficacy of Nab-paclitaxel plus gemcitabine in patients with advanced pancreatic cancer suffering from cholestatic hyperbilirubinaemia-A retrospective analysis.
    European journal of cancer (Oxford, England : 1990), 2018, Volume: 100

    Topics: Adenocarcinoma; Adult; Aged; Albumins; Antineoplastic Combined Chemotherapy Protocols; Cholestasis; Databases, Factual; Deoxycytidine; Feasibility Studies; Female; Gemcitabine; Humans; Hyperbilirubinemia; Male; Middle Aged; Paclitaxel; Pancreatic Neoplasms; Retrospective Studies; Risk Factors; Time Factors; Treatment Outcome

2018
Safety and pharmacology of gemcitabine and capecitabine in patients with advanced pancreatico-biliary cancer and hepatic dysfunction.
    Cancer chemotherapy and pharmacology, 2014, Volume: 73, Issue:1

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biliary Tract Neoplasms; Capecitabine; Deoxycytidine; Female; Fluorouracil; Gemcitabine; Humans; Hyperbilirubinemia; Liver Diseases; Male; Middle Aged; Pancreatic Neoplasms

2014